JS

Jagjit Singh

Active Director Director DIN 02230630
DIN 02230630 First appointment Jun 1991 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 1991
Shareholding value •••• Premium profile

About Jagjit Singh

Data last updated:

Jagjit Singh is a Director at Unimad Pharmaceuticals Pvt Ltd (since 1991). The company operates in Chemicals. Unimad Pharmaceuticals Pvt Ltd reported revenue of ₹20.5 Lakh (FY 2024).

DIN 02230630
Primary Designation Director
Industry Chemicals
First Appointment 12 Jun 1991
Oldest Company Age 43 yrs
Largest company Unimad Pharmaceuticals Pvt Ltd · ₹20.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unimad Pharmaceuticals Pvt Ltd U24232PB1983PTC005268
Director12 Jun 19911983₹20.5 Lakh (FY 2024)Active

Board colleagues of Jagjit Singh

Directorship timeline

Open interactive timeline →
Unimad Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Jagjit Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagjit Singh

Jagjit Singh currently holds 1 directorship: Unimad Pharmaceuticals Pvt Ltd (Director, since 12 Jun 1991, revenue ₹20.5 Lakh (FY 2024)).

Jagjit Singh was first appointed on 12 Jun 1991 as Director at Unimad Pharmaceuticals Pvt Ltd.

The current boards of Jagjit Singh's companies include Babar Kailay (Unimad Pharmaceuticals Pvt Ltd), Jitender Singh (Unimad Pharmaceuticals Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available